Opens in a new tab

La Siddhi Consultancy v Athena Pharmaceutiques (CoA, 14 April 2026)

Date14 April 2026
CourtCoA
DivisionLuxembourg (LU)
Type of actionApplication Rop 223
Case number(s)UPC_CoA_48/2026
Registry referenceUPC-COA-0000048/2026
PartiesLa Siddhi Consultancy Limited. v. Athena Pharmaceutiques SAS, Substipharm

Official decision (PDF) · UPC registry entry

Case timeline

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By an order of 14 April 2026 (UPC_CoA_48/2026), the Court of Appeal rejects La Siddhi Consultancy’s application for suspensive effect against the Milan Central Division’s order of 13 March 2026, which required it to provide EUR 75,000 security for costs in its revocation action on EP 3 592 333 against Athena Pharmaceutiques and Substipharm. The order confirms that suspensive effect remains exceptional and that SME status does not dispense with concrete proof of inability to pay.

Question

Should an appeal against an order for security for costs, brought with leave under Rule 220.2, be given suspensive effect?

Decision

The application is admissible, since Art. 74 UPCA allows suspensive effect for Rule 220.2 orders and prevails over the Rules (paragraphs 8 and 9). It is unfounded: suspensive effect requires exceptional circumstances, such as an appeal that would otherwise be devoid of purpose, a manifestly wrong decision or a serious breach of procedural rights (paragraphs 10 to 13). The applicant shows neither a manifest error nor a breach of the right to be heard, the correctness of the reasoning being a matter for the appeal (paragraph 15), nor inability to pay, SME status alone being insufficient (paragraphs 16 and 17). The appeal keeps its purpose, as a deposit can be refunded or a guarantee released, and Art. 47 of the Charter is not infringed (paragraph 18). No costs order is made (paragraph 19).

Key points for practice

Provisions applied

Agreement on a Unified Patent Court
Art. 69(4) and 74(1)
Rules of Procedure
Rules 1.1, 158, 220.2 and 223
Case law cited
ICPillar v ARM, Court of Appeal, 19 June 2024, Sun Patent Trust v Vivo, Court of Appeal, 25 August 2025, Ocado v Autostore, Court of Appeal, 6 November 2023, Progress Maschinen v AWM, Court of Appeal, 2 May 2024, Meril v Edwards, Court of Appeal, 18 January 2024, Windhager v Bellissa, Court of Appeal, 2 December 2025, Alpina v Cup&Cino, Court of Appeal, 24 March 2026, Belkin v Philips, Court of Appeal, 29 October 2024, Chint v Jingao, Court of Appeal, 20 May 2025, Guardant Health v Sophia Genetics, Court of Appeal, 18 February 2026

Related decisions

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Decisions in the same proceedings

Going further

Lexicon: UPC Court of Appeal.

Dhenne Avocats blog: UPC Appeals: What the Numbers Show.

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

  • UPC_CoA_48/2026 official number

Follow this case

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

  1. 14 April 2026 La Siddhi Consultancy v Athena Pharmaceutiques (CoA, 14 April 2026) Application Rop 223 · UPC_CoA_48/2026
  2. 1 June 2026 La Siddhi Consultancy v Athena Pharmaceutiques (CoA, 1 June 2026) Appeal RoP220.2 · UPC_CoA_48/2026

    L’appel est rejeté : la garantie de 75 000 euros est maintenue, la qualité de PME ne dispensant pas à elle seule de fournir une garantie pour les frais.

What the record states

Nature of the act
Application Rop 223
Outcome (Dhenne Avocats summary)
La cour d'appel rejette la demande d'effet suspensif visant l'ordonnance imposant une garantie de 75 000 EUR, faute d'erreur manifeste, d'atteinte aux droits procéduraux ou de preuve de l'incapacité de payer.
Appeal
Decision of the Court of Appeal.
Instance
Court of Appeal decision.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 3 592 333Mentioned in the analysis (role not qualified)
Also mentioned in 3 other decision(s): La Siddhi Consultancy v Athena Pharmaceutiques (CoA, 1 June 2026) · La Siddhi Consultancy v Athena Pharmaceutiques (CFI, 19 May 2026) · La Siddhi Consultancy v Athena Pharmaceutiques (CFI, 13 March 2026)
not recordednot recordednot recordedEspacenet
links not checked
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.